[fertility problems]{.smallcaps} in the modern high-yielding dairy cow are of considerable economic cost to the dairy industry ([@B44], [@B58]), with both nutritional and metabolic stress contributing to poor reproductive performance. During the early postpartum period high-yielding dairy cows experience negative energy balance (NEB), as the energy demands for lactogenesis exceed energy intake. These increased metabolic demands lead to increased mobilization of body reserves such as fat and protein ([@B86]). A prominent feature of the energy-metabolic response to the NEB state involves reliance on fatty acids and ketones as a source of energy and an increased capacity for mitochondrial fatty acid oxidation in tissues with high oxidative energy demands such as the liver ([@B17], [@B27]).

Oxidation of nonesterified fatty acids (NEFA) in the liver results in the increased production of reactive oxygen species (ROS) ([@B90]), and NEB can result in the onset of oxidative stress, which can lead to disruption of normal metabolism and physiology ([@B66]). The liver undergoes extensive changes during the early postpartum period concomitant with increases in its rate of metabolism and weight ([@B76]). In severe cases this may result in the development of production diseases such as hepatic lipidosis and ketosis ([@B25], [@B41]). Increased lipolysis and subsequent triglyceride accumulation is a potential cause of liver damage ([@B77]) and is therefore likely to affect liver function.

The liver has been estimated to supply up to 90% of glucose requirements in ruminants through hepatic gluconeogenesis ([@B68]) critical to the progression of growth and lactation. Consequently liver is a logical tissue for transcript profiling to identify key regulatory pathways affecting energy generation, carbohydrate, lipid, and amino acid metabolism ([@B88]). Indeed recent oligonucleotide array-based studies in cattle have uncovered a host of genes putatively involved in metabolic processes such as energetic efficiency ([@B32]), ketosis ([@B56]), and adaptation to the onset of lactation ([@B55]) in liver tissue. The recent availability of the bovine genome sequence and of bovine-specific microarrays provides an excellent opportunity to study global gene expression in tissues of interest using a well-controlled and validated approach ([@B11]).

The experiment described here was designed to test the hypothesis that severe NEB (SNEB) in the early postpartum period has profound effects on the global expression of genes regulating liver metabolic processes and its concomitant ability to function normally.

MATERIALS AND METHODS
=====================

### Animal model.

The animal model employed in this study has been described previously ([@B19], [@B66]), and all procedures were carried out under license in accordance with the European Community Directive 86-609-EC. The nutritional and lactational management regime employed were designed to create significant divergence in the energy balance (EB) profiles of cows in early lactation.

In brief, multiparous Holstein-Friesian cows (*n* = 24) were blocked 2 wk prior to expected calving date according to parity, body condition score, and previous lactation yield (average lactation 6,477 ± 354 kg) and randomly allocated to mild (MNEB, *n* = 12) or severe (SNEB, *n* = 12) NEB groups. MNEB cows were fed ad libitum grass silage and 8 kg/day concentrates and milked once daily; SNEB cows were fed 25 kg/day silage and 4 kg/day concentrate and milked three times daily. Measurements of body condition score and EB were used to select cows that showed extremes in EB from each group (MNEB, *n* = 5; SNEB, *n* = 6). Cows were slaughtered on *days 6--7* of the first follicular wave after calving (mean number of days postpartum: MNEB mean 13.6 ± 0.75, range 11--15; SNEB mean 14.3 ± 0.56, range 13--16), based on daily transrectal ultrasonography.

### Liver tissue collection for RNA and TAG analysis.

The entire liver was removed within 15--30 min after slaughter and weighed. Samples weighing ∼1 g were dissected, rinsed in RNase-free phosphate buffer, snap-frozen in liquid nitrogen, and stored at −80°C. For triacylglyceride (TAG) analysis, total lipids were extracted from 50 mg samples of liver as previously described ([@B21]).

### Blood sampling and metabolite assays.

Stabilized (EDTA-treated) whole blood samples were collected on the day of slaughter by jugular venipuncture for hematological analysis. Blood samples were analyzed for glucose, NEFA, β-hydroxybutyrates (BHB), and urea using appropriate kits and an ABX Mira autoanalyzer (ABX Mira, Cedex, France). All metabolite assay coefficients of variation were low and typically \<5%.

### RNA extraction and quality analysis.

Total RNA was prepared from 100--200 mg of fragmented frozen liver tissue using the TRIzol reagent (Sigma-Aldrich, Dorset, UK). Tissue samples were homogenized in 3 ml of TRIzol reagent and chloroform and subsequently precipitated using isopropanol (Sigma Chemical). RNA samples were stored at −80°C. We treated 20 μg of total RNA from each sample for genomic DNA contamination with the RNase-free DNase set (QIAGEN, Crawley, West Sussex, UK) and purified it using the RNeasy mini kit in accordance with guidelines supplied (QIAGEN). RNA quality and quantity were assessed using automated capillary gel electrophoresis on a Bioanalyzer 2100 with RNA 6000 Nano Labchips according to manufacturer\'s instructions (Agilent Technologies Ireland, Dublin, Ireland). Samples of RNA had 28S/18S ratios ranging from 1.8 to 2.0 and RNA integrity number values of between 8.0 and 10.0, which indicates that RNA samples are of high quality and suitable for microarray analysis.

### cDNA synthesis.

From this reaction, 1 μg of DNase-treated RNA was reverse transcribed using AMV reverse transcriptase and 500 ng random hexamer primers in a 20 μl reaction (reverse transcription system kit; Promega, Madison, WI). A quantity (0.39 ng) of kanamycin mRNA (Promega) was spiked into each sample as an exogenous control (Promega). A master mix of reagents was prepared for the above reaction to minimize potential variation from pipetting. Negative control samples were also prepared by including all reagents as above for the cDNA synthesis, minus the reverse transcriptase enzyme to ensure there was no genomic DNA contamination.

### Primer design.

Gene-specific primers ([Table 1](#T1){ref-type="table"}) were designed online using the Primer3 web-based software program (<http://frodo.wi.mit.edu/primer3>). Primer specificity was determined using the basic local alignment search tool from the National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov/BLAST/>). All oligonucleotides were commercially synthesized as highly purified, salt-free products (Sigma Genosys). For each gene, PCR conditions were optimized by conventional PCR amplification using Go Taq Flexi DNA Polymerase (Promega), with the addition of 1 μl cDNA (1 μg/μl) and 1 μl of 20 μM forward and reverse primer mix. Standards for absolute real time RT-PCR assays were prepared from PCR products generated from cDNA, which was subsequently purified using QIquick PCR purification columns (QIAGEN, Crawley, West Sussex, UK). Exact concentrations of purified PCR product was determined using the NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and the presence of a single product confirmed by electrophoresis on a 1.5% (wt/vol) ethidium bromide agarose gel.

###### 

Oligonucleotide forward and reverse primer sequences (5′-3′), PCR product length, linearity, efficiency, and % intra-assay variation of real-time RT-PCR reactions

  Gene        Primer Sequence                Product Size, bp   Accession No.                  r^2^     E      \% Variation
  ----------- ------------------------------ ------------------ ------------------------------ -------- ------ --------------
  *SAA1*      `F CAACTACAGGGGTGCAGACA`       241                [XM_867996](XM_867996)         0.998    1.03   ± 3.9
              `R AGCAGGTCTGAAGTGGTTGG`                                                                         
  *GPX3*      `F ACACGAGTACAGGGCCACAT`       201                [NM_174077](NM_174077)         0.997    1.04   ± 5.5
              `R GGTAGGGTGAGGTCCTGGTT`                                                                         
  *FOXA3*     `F GCCATGTCATCCCTGTCTCT`       176                [NM_001033119](NM_001033119)   0.996    1.08   ± 0.1
              `R CCGGCAAGAACCAGACTTTA`                                                                         
  *ANGPT4*    `F GAATTTCCAACGGAACTGGA`       113                [EU599227](EU599227)           0.98     1.28   ± 21.0
              `R GAGAGTAGGTTGCCCTGCTG`                                                                         
  *ADIPOR2*   `F CCAGAGGAGCCCCACAGT`         117                [BT025411](BT025411)           1.0      0.89   ± 6.0
              `R GCCATCTCGCGTCTTCTC`                                                                           
  CD36        `F CAGCATCAGCAAGGCATTA`        115                [BC103112](BC103112)           0.99     1.23   ± 1.5
              `R CAGAAGAGCTGTAGAACGTGGA`                                                                       
  CLDN1       `F CCATTGCTAAAAATGACTTAGCC`    120                [BT021861](BT021861)           0.999    1.03   ± 0.1
              `R AAGGAATGCTATCTCCCCTCA`                                                                        
  *CPT1A*     `F TCCTGGTGGGCTACCAATTA`       181                [FJ415874](FJ415874)           0.999    0.99   ± 2.6
              `R TGCGTCTGTAAAGCAGGATG`                                                                         
  *CPT1B*     `F GCGCTTTGGGAACCAGAT`         128                [NM_001034349](NM_001034349)   0.998    1.08   ±16.5
              `R CCCCCTCCTCCACTCTGT`                                                                           
  HP          `F TCGTCGTTCACGACAAGG`         129                [BC109668](BC109668)           0.995    1.13   ± 0.1
              `R TTTTCCGAACCCAGTCCA`                                                                           
  IL8         `F AAAAGACACAAACAGAAAGACCTC`   140                [AF232704](AF232704)           0.99     1.06   ± 0.0
              `R GCATCTCAAAAGTAGGACTTCCA`                                                                      
  *TNFα*      `F CATCCTGTCTGCCATCAAGA`       147                [EU276079](EU276079)           0.995    0.93   ± 19.4
              `R TAGTCCGGCAGGTTGATCTC`                                                                         
  *ACADVL*    `F ATCGTCCACCAGGAACTGAG`       130                [BT030546](BT030546)           0.999    1.05   ± 5.2
              `R GCTGCAGCAGAAACTGTTCA`                                                                         
  *PPARA*     `F TTGTGGCTGCTATCATTTGC`       135                [NM_001034036](NM_001034036)   0.998    1.0    ± 2.9
              `R AGAGGAAGACGTCGTCAGGA`                                                                         
  *PPARG*     `F GTGAAGCCCATTGAGGACAT`       149                [NM_181024](NM_181024)         0.999    0.95   ± 2.4
              `R AGCTGCACGTGTTCTGTCAC`                                                                         
  *PPARD*     `F CACTCTCACTGCTGGACCAA`       194                [NM_001083636](NM_001083636)   0.99     0.98   ± 2.9
              `R GCAGATCCGCTCACATTTCT`                                                                         
  *RxRG*      `F ATGAAGATATGCCCGTGGAG`       126                [NM_001075408](NM_001075408)   0.991    1.01   ± 11.8
              `R CAGCGTGGCATATATTGGTG`                                                                         
  *HSP90*     `F GGCGCTGATATCTCCATGAT`       119                [BC151818](BC151818)           0.99     1.07   ± 0.9
              `R GACTCCCAGGCATACTGCTC`                                                                         
  *FABP1*     `F GGAGTTCATGACTGGGGAGA`       135                [NM_175817](NM_175817)         0.99     1.22   ± 12.7
              `R CCCTTCGTCATGGTACTGGT`                                                                         
  *FADS2*     `F CTGACTGGTGATGGACCTGA`       127                [NM_001083444](NM_001083444)   0.99     1.09   ± 5.6
              `R TCCCTATGGATCCAGTCTGC`                                                                         
  GSTA4       `F TTCATGCCATAGGACAGCAG`       111                [BT020960](BT020960)           0.9997   1.02   ± 4.3
              `R ACGACAGAGCTGGATCACG`                                                                          

r^2^, Linearity; E, efficiency; F, forward; R, reverse.

### Real-time RT-PCR.

Real-time RT-PCR analysis was performed using the ABI 7500 Fast real-time PCR System (Applied Biosystems, Warrington, UK). Genes were chosen to be representative of those in the top three Ingenuity Pathways Analysis (IPA) networks and the more biologically interesting of the most up- and downregulated genes. The stability of the expression of several control or housekeeping genes, including GAPDH, β-actin, RPL-19, and 18S rRNA, across all samples in this study was investigated as part of a preliminary study. Resulting expression data were analyzed using GeNorm software package, and as statistically significant differences in expression of these genes existed between samples, it was concluded that none of these genes were suitable as a housekeeping genes and consequently relative real-time PCR could not be conducted. Thus, an absolute real-time RT-PCR methodology employing an exogenous reference control (i.e., a kanamycin resistance gene) to normalize real-time PCR results was performed to measure the expression of genes. The application of this method has previously been described ([@B19], [@B23], [@B61], [@B83]). Real-time RT-PCR assays were performed to detect expression of the exogenous kanamycin control in synthesized cDNA. External standards were run on the same plate in triplicate. Nontemplate controls were included on every plate for each gene product. To minimize variation, all samples included in each analysis were derived from the same cDNA batch and prepared under the same conditions, and samples were run in duplicate. All samples for a particular gene were assayed on the same plate, thereby eliminating intra-assay variation, and specificity of the reaction products was also confirmed by dissociation curve analysis and gel electrophoresis.

We amplified 1 μl of first-strand cDNA from standards and samples in a 20 μl volume using 10 μl Power SYBR Master Mix and 1 μl of 20 μM forward and reverse primer mix and 8 μl nuclease-free water (Promega). The real-time PCR temperature profile consisted of 15 min incubation at 95°C for SYBR Green activation. The cycling conditions consisted of 35 cycles of 30 s at 95°C, the optimal annealing temperature for each individual gene for 30 s, 30 s at 72°C for primer extension followed by an amplicon-specific melt curve analysis. A melting curve analysis was performed for each amplicon between 50 and 95°C to ensure the absence of nonspecific products such as primer dimers. Nonreverse transcribed total RNA was included as a control for the presence of genomic DNA contaminants. All samples were assayed on the same run, thereby eliminating interassay variation, and specificity of the reaction products was confirmed by melt curve analysis and gel electrophoresis.

### Statistical analysis.

Blood metabolite and real-time RT-PCR data were analyzed using MIXED procedure of SAS ([@B81]). The type of variance-covariance structure used was chosen depending on the magnitude of the Akaike criterion (AIC) for models ran under compound symmetry, unstructured, autoregressive, or Toeplitz variance-covariance structures. The model with the lowest AIC was chosen. The PDIFF (predicted difference) and CONTRAST (for orthogonal contrasts) statements in SAS were used, and Tukey-Kramer test was used to examine pair-wise comparisons of treatment means. Real-time RT-PCR data were log-transformed prior to analysis to stabilize variances. Data are presented as back-transformed least square means and their confidence intervals.

The r^2^ and amplification efficiency (E) values for real-time RT-PCR were calculated from linear regression analysis of log (input cDNA) versus threshold cycle number (C~t~) plot ([Table 1](#T1){ref-type="table"}). The slope for each set of standards was used to determine E = 10^(−1/slope)^ − 1. Intra-assay variation was determined from the average standard deviation across the quantification range and presented as percentage using the formula: ± % variation = \[(E + 1)^SD^ − 1\] × 100 ([@B78]).

### Microarray hybridization.

Gene expression was determined using a 24,027 probe set bovine oligonucleotide array (Affymetrix), representing ∼23,000 bovine transcripts based on the original mapping using Unigene build 57 (March 24, 2004). RNA from each cow was hybridized to a separate array. All 11 RNA samples were hybridized and scanned by the German Resource Centre for Genomics Research, Germany (RZPD), according to the manufacturer\'s instructions.

### Microarray analysis.

All microarray analysis including preprocessing, normalization, and statistical analysis was carried out using R (R, 2007) version 2.6 and Bioconductor ([@B22]) version 2.1, as described by Morris et al. ([@B66]). Data were quality assessed before and after normalization using a number of in-built quality control methods implemented in the Bioconductor affycoretools and associated packages to identify problems if they existed with array hybridization, RNA degradation, and data normalization. Microarray data were preprocessed using the mmgMOS normalization method ([@B38], [@B72]) using the default settings and differential expression (DE) was analyzed using the puma DE method both implemented in the Bioconductor package "puma" ([@B53], [@B71], [@B72], [@B80]). The puma method uses a Bayesian hierarchical model to calculate the probability of positive likelihood ratio (PPLR). The PPLR associates probability values of being differentially expressed, which is a measure of the false positive detection of differential expression to each ratio and generates lists of genes ranked by the probability of DE. This PPLR statistic was converted into "*P*-like values" using the recommended formula in the puma method prior to subsequent analysis. Differentially expressed genes (DEG) detected by the puma method were also compared with those detected by the Limma ([@B84]) and rank product ([@B6]) methods.

As many of the original annotations for the Affymetrix bovine chip are erroneous ([@B12], [@B21]), Affyprobeminer ([@B52]) redefines the chip definition files (CDFs) for Affymetrix chips, taking into account the most recent genomic sequence information. The remapped annotations were determined using the "bovineccdscdf" cdf annotation file downloaded from the Affyprobeminer website that returned Entrez Gene gene name identifiers ([@B18]).

This remapped annotation includes mappings to all RefSeq (mature RNA protein coding) transcripts, and validated complete coding sequences in GenBank Annotations were also supplemented by interrogating the Ensembl bos-taurus database version 46 using the biomaRt package in Bioconductor and manual annotation where possible with recent entries in Entrez Gene.

The Entrez Gene IDs of DEG were then submitted to DAVID ([@B14], [@B34]) to determine gene function and to cluster genes into functionally significant gene clusters and also to determine significant biological pathways through KEGG ([@B39]). The official gene names corresponding to the Entrez Gene of the remapped annotations was used as the "population" background gene list in DAVID as opposed to the default DAVID bos-taurus gene list. This was to ensure that the calculated EASE scores were not overly conservative, resulting in a failure to detected significant differences.

### Pathway analysis.

To examine the molecular functions and genetic networks, the microarray data were further analyzed using IPA (v. 7.5, Ingenuity Systems, Mountain View, CA; <http://www.ingenuity.com>), a web-based software application that enables identification of biological mechanisms, pathways, and functions most relevant to experimental datasets or genes of interest ([@B5], [@B56]).

A dataset containing gene identifiers and corresponding expression and *P*-like values was uploaded into the application as described by Morris et al. ([@B66]). Briefly, each identifier was mapped to its corresponding gene object in the Ingenuity knowledge base. A *P*-like value of *P* \< 0.05 from the puma analysis was set to identify genes whose expression was significantly differentially up- or downregulated. These genes, called "focus" genes, were overlaid onto a global molecular network developed from information contained in the Ingenuity knowledge base. Networks of these focus genes were then algorithmically generated based on their connectivity. Network analysis returns a score that ranks networks according to their degree of relevance to the network eligible molecules in the dataset. The score takes into account the number of network eligible molecules in the network and its size, as well as the total number of network eligible molecules analyzed and the total number of molecules in the knowledge base that could potentially be included in networks.

RESULTS
=======

### EB model.

Average EB from *day 2* postcalving to slaughter for MNEB and SNEB groups was = −1.7 ± 1.17 unité fourragère lait (UFL)/day and −6.1 ± 1.03 UFL/day respectively (*P* \< 0.05) as previously described ([@B93]). Systemic concentrations of glucose (4.08 ± 0.15 vs. 2.66 ± 0.15 mmol/l) were higher (*P* \< 0.001) in the MNEB cows, while BHB (3.70 ± 0.70 vs. 0.53 ± 0.09 mmol/l) (*P* \< 0.001), NEFA (1.40 ± 0.14 vs. 0.34 ± 0.05 mmol/l) (*P* \< 0.001), and hepatic TAG concentrations (116.0 ± 7.8 vs. 30.0 ± 11.8 mmol/g) (*P* \< 0.05) were higher in the SNEB cows as reported by Fenwick et al. ([@B19]). Urea was not different (*P* = 0.17) between MNEB and SNEB (4.2 ± 0.46 vs. 5.1 ± 0.31 mmol/l) groups ([@B21]).

### Gene expression.

From a total of 5,739 Affyprobeminer annotated genes, 5,229 genes were mapped to the IPA database. However, a cut-off *P*-like value of *P* \< 0.05 resulted in a total of 416 differentially expressed genes (189 up- and 227 downregulated) using the puma method. IPA was used to place the DEG into different function and disease categories. Of the 416 DEG, 341 genes were network eligible with 298 genes being function/pathway or list eligible. Among the network-eligible genes, 154 were upregulated (Supplementary Table S1), while 187 genes were downregulated (Supplementary Table S2).[^1^](#FN1){ref-type="fn"} A comparison between the puma method and the limma and rank product methods revealed that the puma method included 89% of DEG detected by the Limma method and 60% of the DEG detected by the rank product method with a total of 41 DEG common to all three methods. Overall, the puma method detected the greatest number of DEG.

Biological categories with the largest number of downregulated genes were cell signaling, cardiovascular development and function, organ morphology, inflammatory disease, and respiratory disease, while genes associated with cell morphology, amino acid metabolism, small molecule biochemistry, lipid metabolism, and cell cycle were the categories containing the greatest number of genes upregulated by SNEB according to IPA terminology. Gene classification according to canonical signaling pathways revealed that some of the nuclear hormone receptor superfamily including liver X receptors (LXRs) and the retinoid X receptor (RXR) as well as amino acid metabolism were the pathways most affected by EB status ([Table 2](#T2){ref-type="table"}). The top 20 molecular and cellular functions most significantly affected by EB are shown in [Fig. 1](#F1){ref-type="fig"}.

###### 

Gene classification according to canonical signaling pathways using IPA

  Pathway                                             *P* Value   %DEG   Genes
  --------------------------------------------------- ----------- ------ -------------------------------------------------------------------------------------------------------------------
  Pyruvate metabolism                                 0.00018     6.2    ***ACACA, AKR1A1, ALDH1A1, PKLR,*** *HADHA, HADHB, LDHA, LDHB, PC*
  LXR/RXR activation                                  0.00020     11.7   ***ABCG8, ACACA, CD14,*** *APOA1, ARG2, CCL2, CD36, IL1A, IL1RN, RXRG*
  Fatty acid metabolism                               0.00092     5.3    *CPT1B, ACADSB, HADHA, ACADVL, SLC27A4, CPT2, HADHB,* ***ALDH1A1, CYP2E1, HSD17B4***
  FXR/RXR activation                                  0.00098     9.0    ***ABCG8****, APOA1,****FOXA3,*** *IL1A, IL1RN, **LIPC,** OSTALPHA, **PKLR,**SCARB1*
  Propanoate metabolism                               0.0019      6.4    ***ACACA***, ACADSB, ACADVL, ***ALDH1A1***, HADHA, HADHB, LDHA, LDHB,
  Arginine and proline metabolism                     0.0036      5.0    ***ALDH1A1****, ARG1, ARG2, **GAMT,** OAT, ODC1, **OTC,** P4HA2, **SAT1,***
  Urea cycle and metabolism of amino groups           0.0037      7.5    ***OTC****, **GAMT,** OAT, ARG2, ODC1, ARG1*
  Valine, leucine and isoleucine degradation          0.0049      7.4    *HADHB, **ALDH1A1,** ACADVL, **HIBADH,** ACADSB, **AOX1, HSD17B4,** HADHA*
  β-Alanine metabolism                                0.0074      6.1    *HADHB, **ALDH1A1,** DPYD, ACADVL, ACADSB, HADHA*
  Aryl hydrocarbon receptor signaling                 0.0078      6.4    ***TGM2, NR2F1,** RXRG, FOS, **RB1,** IL1A, **ALDH1A1,** NQO2, **NFIA,** GSTM4*
  LPS/IL-1-mediated inhibition of RXR function        0.0107      5.5    ***ABCG8, ALDH1A1, LIPC,** SCARB1, CPT1B, CPT2, GSTM4, **FABP1, CD14, CES2*** (includes ***EG:8824***), *SLC27A4*
  Tryptophan metabolism                               0.0178      3.4    *HADHB, AADAT, **ALDH1A1, CYP2E1,** DDC, **AOX1, HSD17B4,** HADHA*
  Fatty acid biosynthesis                             0.0282      4.0    *OXSM,****ACACA***
  IL-10 signaling                                     0.0282      8.4    *FOS, IL1A, IL1RN, **CD14,** ARG2, **CHUK***
  Glutamate receptor signaling                        0.0302      3.0    ***SLC1A4, GNG11, SLC17A2***
  Glutathione metabolism                              0.0355      5.1    *GPX3, GSTM4, GCLM, IDH3A, IDH1*
  Glycolysis/gluconeogenesis                          0.0372      4.2    ***AKR1A1, ALDH1A1, PKLR, GALM,** LDHB, LDHA*
  Fatty acid elongation in mitochondria               0.0398      4.6    *HADHB, **HSD17B4,** HADHA*
  Hepatic fibrosis/hepatic stellate cell activation   0.0498      6.6    ***SMAD2, VCAM1,** IL1A, CTGF, CCL2, **CYP2E1, IGFBP3, CD14, AGTR1***

The %DEG is the proportion of differentially expressed genes (DEG) relative to the total no. of genes in the specific canonical pathway. Downregulated genes are highlighted in boldface, upregulated genes are in lightface. IPA, Ingenuity Pathways Analysis.

![Classification of differentially expressed genes (DEG) according to top 20 molecular and cellular functions, most significantly affected by energy balance (EB) using Ingenuity Pathways Analysis. The blue bars indicate the likelihood \[−log (*P*-value)\] that the specific molecular and cellular function category was affected by negative energy balance compared with others represented in the list of DEG. The number of up- and downregulated genes in each group is represented on the righthand side by red and green numbers, respectively. The cut-off (yellow line) is shown at *P* \< 0.05 (1.301 log scale).](zh70151035290001){#F1}

The most dramatically upregulated gene in SNEB animals was [d]{.smallcaps}-aspartate oxidase (DDO) with a fold-change of 6.1 (*P* \< 0.05); carnitine palmitoyltransferase 1B (CPT1B) also appeared in the top five with a 5.5-fold higher abundance in SNEB cows, as did angiopoietin-like 4 (ANGPTL4) (5.5-fold upregulated) and retinoid X receptor gamma (RXRG) (4.9-fold upregulated) (*P* \< 0.001). There was also increased expression of other genes involved in lipid transport, apolipoprotein A1 (ApoA1) (*P* \< 0.05), and lipid oxidation, very long chain acyl-Coenzyme A dehydrogenase (ACADVL) (*P* \< 0.001). The gene that displayed the most dramatic downregulation was fatty acid desaturase 2 (FADS2) (19.6-fold decrease) (*P* \< 0.001), and the insulin-like growth factor binding protein acid labile subunit (IGFBPALS) was also in the top five most downregulated genes (6.4-fold decrease) (*P* \< 0.001). Twenty genes were validated by real-time PCR, and a high level of consistency was observed between microarray and real-time PCR in terms of both direction of fold-change and magnitude ([Table 3](#T3){ref-type="table"}). Of the 41 genes found to be differentially expressed by all three methods of statistical analysis, almost 27% (11 genes) have been validated by real-time RT-PCR. Of these 11 genes, all except one gene (ANGPTL4, nonsignificant) were in agreement with array data in terms of fold direction and significance.

###### 

Microarray validation with real-time RT-PCR on selected genes

              Real-time Data                                                          
  ----------- ---------------------- ---------------------- ------- --------- ------- ---------
  *SAA1*      253 (70--908)          787 (245--2527)        +3.1    0.17      +1.7    0.2
  *GPX3*      40.9 (16--102)         437 (191--1000)        +10.7   \<0.01    +3.7    \<0.001
  *FOXA3*     4.53 (2.07--9.9)       1.91 (0.93--3.9)       −2.4    0.10      −2.0    \<0.001
  *ANGPTL4*   0.176 (0.151--0.205)   0.199 (0.174--0.228)   +1.13   0.25      +5.4    \<0.001
  *ADIPOR2*   0.833 (0.594--1.167)   1.092 (0.803--1.485)   +1.3    0.21      +1.4    \<0.05
  *CD36*      0.05 (0.04--0.07)      0.12 (0.08--0.16)      +2.4    \<0.01    +1.8    \<0.001
  *CLDN1*     1.53 (1.12--2.09)      1.33 (1.0--1.77)       −1.2    0.48      −1.3    0.32
  *CPT1B*     0.017 (0.01--0.028)    0.084 (0.052--0.134)   +4.9    \<0.001   +5.5    \<0.001
  *CPT1A*     0.203 (0.034--0.373)   0.694 (0.539--0.849)   +3.4    \<0.01    nd      nd
  *HP*        1.37 (0.26--7.35)      5.32 (1.15--2.46)      +3.9    0.21      +1.0    0.82
  *IL8*       0.001 (0.001--0.002)   0.001(0.001--0.002)            0.79      +1.1    0.43
  *TNFα*      0.025 (0.017--0.032)   0.015 (0.008--0.022)   −1.7    0.09      −1.1    0.59
  *ACADVL*    2.2 (1.774--2.777)     3.3 (2.715--4.084)     +1.5    \<0.05    +1.4    \<0.001
  *PPARA*     0.128 (0.102--0.161)   0.116 (0.092--0.146)   +1.1    0.52      +1.0    0.9
  *PPARG*     0.006 (0.004--.009)    0.005 (0.003--.007)    −1.2    0.2       +1.0    0.96
  *PPARD*     0.028 (0.022--0.037)   0.031 (0.024--.041)    +1.1    0.6       +1.0    0.93
  *RXRγ*      0.073 (0.0--0.292)     0.514 (0.318--0.71)    +7.04   \<0.05    +4.9    \<0.001
  *HSP90*     13.1 (9.8--17.5)       10.8 (8.3--14.1)       −1.2    0.32      −1.04   0.69
  *FABP1*     11.19 (7.94--15.76)    6.31 (4.64--8.59)      −1.8    \<0.05    −1.3    \<0.01
  *FADS2*     0.236 (0.139--0.398)   0.027 (0.016--0.043)   −8.74   \<0.001   −19.6   \<0.001
  *GSTA4*     0.319 (0.181--0.559)   0.2 (0.12--0.334)      −1.6    0.2       −1.2    0.27

Values are back-transformed least square means followed by the 95% confidence limits and are expressed as pg per &mu;g of reversed transcribed RNA. nd, Not determined; MNEB, mild negative energy balance; SNEB, severe negative energy balance.

From IPA, 36 networks (*P* \< 0.05) were identified with 20 networks each having 10 or more focus genes among the DEG. The three top networks identified were lipid metabolism, molecular transport small molecule biochemistry (*network \#1*, score 43, 27 focus molecules) ([Fig. 2](#F2){ref-type="fig"}); lipid metabolism, small molecule biochemistry, cell cycle (*network \#2*, score 40, 26 focus molecules) ([Fig. 3](#F3){ref-type="fig"}); and gene expression, cellular compromise, DNA replication, recombination, and repair (*network \#3*, score 38, 25 focus molecules) ([Fig. 4](#F4){ref-type="fig"}).

![*Network \#1*: lipid metabolism, molecular transport, small molecule biochemistry. The network is displayed graphically as nodes (genes). The node color intensity indicates the expression of genes, with red representing upregulation and green downregulation in severe negative energy balance (SNEB) versus mild negative energy balance (MNEB) liver. The fold value is indicated under each node. The shapes of nodes indicate the functional class of the gene product, and the lines indicate the type of interaction (Supplementary Fig. S1).](zh70151035290002){#F2}

![*Network \#2*: lipid metabolism, small molecule biochemistry, cell cycle. The network is displayed graphically as nodes (genes). The node color intensity indicates the expression of genes, with red representing upregulation and green downregulation in SNEB versus MNEB liver. The fold value is indicated under each node. The shapes of nodes indicate the functional class of the gene product and the lines indicate the type of interaction (Supplementary Fig. S1).](zh70151035290003){#F3}

![*Network \#3*: gene expression, cellular compromise, DNA replication, recombination, and repair. The network is displayed graphically as nodes (genes). The node color intensity indicates the expression of genes, with red representing upregulation and green downregulation in SNEB versus MNEB liver. The fold value is indicated under each node. The shapes of nodes indicate the functional class of the gene product and the lines indicate the type of interaction (Supplementary Fig. S1).](zh70151035290004){#F4}

*Network \#1* included 11 upregulated and 16 downregulated genes in SNEB cows. The upregulated genes included CPT1B, CD36 antigen (CD36), and RXRG. Also upregulated were the patatin-like phospholipase domain containing 2 (PNPLA) gene, the cell growth regulator with EF-hand domain 1 (CGREF[@B1]), and lactate dehydrogenase A and B (LDHA/B). Downregulated genes in SNEB cows include fatty acid binding protein 1, liver (FABP1), septin 4 (SEPT4), transglutaminase 2 (TGM2), hydroxysteroid (17-beta) dehydrogenase 2 (HSD17B2), thymine-DNA glycosylase (TDG), thiopurine S-methyltransferase (TPMP), conserved helix-loop-helix ubiquitous kinase (CHUK), and inositol hexakisphosphate kinase 2 (IHPK2).

The second most significant network, *network \#2*, encompassed 17 upregulated and 9 downregulated genes. The upregulated genes in this network include glycerol kinase (GK), branched chain ketoacid dehydrogenase kinase (BCKDK), CD69 molecule (CD69), plasminogen activator, urokinase receptor (PLAUR), and interleukin 1 receptor antagonist (IL1RN). Chemokine (C-X-C motif) receptor 4 (CXCR4) was also observed to have increased expression in SNEB cows as was the cell surface antigen transmembrane 4 L six family member 1 (TM4SF1) and regulator of G-protein signaling 16 (RGS16). Genes downregulated by SNEB in this network include ADP-ribosylation factor-like 4D (ARL4D), RAB5A member RAS oncogene family, SMAD family member 2 (SMAD2), and SGT1 suppressor of G2 allele of SKP1 (SUGT1).

*Network \#3* included 9 upregulated and 16 downregulated genes. Genes upregulated include carnitine palmitoyl transferase (CPT2); v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS); glutathione S-transferase mu 4 (GSTM4); H1 histone family, member 0 (H1F0); inhibitor of DNA binding 2 (ID2); lysophosphatidylcholine acyltransferase 3 (LPCAT3); optineurin (OPTN); and ring finger protein 4, (RNF4). Some genes downregulated include phenylalanyl-tRNA synthetase 2, mitochondrial (FARS2), junction protein, alpha 1 (GJA1), nuclear factor I/A (NFIA), histone acetyltransferase 1 (HAT1), selenium binding protein 1 (SELENBP1), and retinoblastoma 1 (RB1).

DISCUSSION
==========

As previously discussed the animal model used in this study generated two groups of high-yielding dairy cows divergent in EB status ([@B19], [@B54]). Given the well-documented disparity between feed intake capacity and lactational energy output in the early postpartum period, dairy cows typically experience some degree of NEB. Our aim, therefore, in generating our control group of cows was to establish an EB status as close to parity as was practical within an early postparturient context. Additionally, all animals selected exhibited no detectable signs of clinical conditions such as lameness, hypocalcaemia, ketosis, endometritis, or mastitis, typical of the postparturient period and that might confound the interpretation of the hepatic gene expression profiles generated. Furthermore, expression of genes encoding IL8, Hp, TNFa were not different among treatment lending support to these observations.

Previous studies conducted on liver tissues harvested from this animal model focused on specific adaptations and effects of SNEB on expression of selected genes critical to metabolism ([@B19]). However, it is known that biological change is more likely due to coordinated small changes in a large set of genes, and recent studies by Morris et al. ([@B66]) and Wathes et al. ([@B93]) have examined global affects of NEB on spleen and uterine tissues from this animal model, respectively, using the Affymetrix 23k bovine microarray. In this study we chose to examine the influence of an SNEB condition on gene expression profile in the liver, due to its critical importance to animal metabolism and wellbeing. In contrast to the study conducted by Loor et al. ([@B56]), which examined the effects of nutrition-induced ketosis on gene networks in dairy cows, the study reported here uses differential feed intake in conjunction with different milking frequencies to induce NEB in high-yielding dairy cows. This study, for the first time, also discusses SNEB and the consequent alterations in the expression of genes and associated pathways controlling cell proliferation, cell cycle, cell signaling, and tissue repair.

The nature of the DEG indicates that SNEB affects expression of genes encoding proteins and enzymes involved in a broad range of biological functions. Cows in SNEB displayed increased expression of genes involved in lipid transport and catabolism. It has been previously documented that SNEB specifically attenuates expression of IGF-1, IGFBP-3 to IGFBP-6, and IGFALS mRNA, while increasing IGFBP-2 mRNA synthesis ([@B19]). In the current study, IGFALS was listed among the top five most downregulated genes by SNEB. In agreement with this finding, expression of this gene was decreased by \>14-fold when examined by real-time RT-PCR ([@B19]). Although IGF-1 expression remained unaffected on the array, in agreement with the observations of Loor et al. ([@B56]), genes encoding the binding proteins IGFBP3 and IGFALS were downregulated, while IGFBP2 was increased in SNEB cows. These results are also consistent with real-time PCR analysis of hepatic tissue from these animals ([@B19]).

DDO was the most upregulated gene in SNEB animals. The protein it encodes has been previously detected in the peroxisomes of bovine kidney and liver ([@B96]) and catalyses the oxidation of [d]{.smallcaps}-aspartate to yield oxaloacetate, ammonia, and hydrogen peroxide. As oxaloacetate deficiency is likely to be limiting the citric acid cycle in SNEB animals, the activation of this gene may provide an alternative mechanism of oxaloacetate production for energy generation during this time period. The FADS2 gene was found to be most downregulated on the microarray. This gene encodes the enzyme responsible for controlling the synthesis of long chain polyunsaturated fatty acids (PUFA) ([@B70]); however, a link between SNEB and depressed PUFA synthesis has not been reported thus far.

Also amongst the five most upregulated genes were CPT1B and RXRG. On examination of gene networks, it was observed that *network \#1* centered on a well-established response to NEB, lipolysis. Expression of CPT1B and RXRG genes was validated here by real-time RT-PCR and is critical to the lipid metabolic process and fatty acid beta-oxidation ([@B7], [@B30]). As CPT1B is involved in transferring long-chain fatty acids from the cytosol to the mitochondrial matrix to undergo beta-oxidation ([@B7], [@B63]) this finding was not surprising. Although the expression of this gene has previously been reported as being muscle specific ([@B3]), real-time RT-PCR employed in the current study validated the detection of transcript expression of CPT1B in the liver and confirmed that it is upregulated by SNEB. Expression of the liver-specific CTP1A, which is not represented on the microarray, was also measured using real-time PCR and found to also have increased expression in SNEB animals. This would suggest, for the first time, that at least two forms of CPT are expressed in the liver. However, absolute measurement of the mRNA transcript of the CPT1A gene indicated that its expression was at least 10-fold higher than that of CPT1B, establishing it as the predominant variant. The validation of RXRG was a particularly good indicator of the accuracy of both platforms of expression measurement, as it was found that other isoforms of this transcriptional regulator were not differentially expressed, when examined with both methods.

The PNPLA gene encodes a protein that possesses TAG lipase activity ([@B37]). Expression of this gene was upregulated by SNEB, and increased mRNA levels have similarly been observed in fasting mice ([@B92]). In addition, LDHA/B genes are involved in the carbohydrate metabolic process, and it has been documented that liver damage results in elevated expression of LDH ([@B40], [@B48]), possibly indicating a clinical sign of SNEB in cows. Microarray results indicated that FABP1 gene expression was reduced in SNEB cows. Similarly, the FABP1 gene was decreased in SNEB cows when analyzed by real time RT-PCR. Bionaz et al. ([@B4]) reported reductions in bovine hepatic expression of FABP1 in dairy cows during the early postpartum period. While more recently, Kuhla et al. ([@B45]) reported a dramatic downregulation of FABP1 in dairy cows that underwent feed restriction and suggested that this may be an attempt to limit fatty acid oxidation and hepatic TAG accumulation associated with NEB. Expression of IHPK2, which may act as an energy reserve protein ([@B79]), was also downregulated in SNEB cows.

Furthermore, within IPA *network \#1* there appeared to be a general downregulation of genes involved in cell cycle and tissue growth and repair. The increased expression of the cell growth regulator CGREF1 may be in response to the stress that SNEB cows are likely to endure. Coincidentally, it is known that the EF-hand domain of the CGR11 protein is essential for growth inhibitory activity by promoting cell cycle arrest and negative regulation of cellular proliferation ([@B16]). The septins are polymerizing scaffold proteins involved in cytoskeletal organization in mitosis, exocytosis, and other cellular processes ([@B42]). SEPT4 knockout studies have recently reported that the gene supports suppressive modulation of processes associated with liver diseases ([@B36]). The observed reduction in SEPT4 expression in SNEB cows may be a contributing factor in what appears to be a trend toward compromised liver function. Given that Piacentini et al. ([@B74]) reported the proliferative phase of hepatocytes to be accompanied by a 10-fold increase in TGM2 mRNA levels, we suggest that the reduction in expression observed here is indicative of reduced capability of liver to recover from SNEB at this time. However, increased levels of expression of this gene are also associated with apoptotic function ([@B60]), and reduced expression may signify deregulated cell growth. Likewise, the HSD17B2 gene is involved in estrogen metabolism. However, reduced levels are associated with unregulated cell cycle ([@B28], [@B29]), suggesting that the reduction observed here may have a negative impact on normal liver processes.

Severe NEB also resulted in reduced expression of TDG, which codes for a protein involved in DNA repair ([@B89]). TPMT, which catalyses the *S*-methylation of aromatic and heterocyclic sulfhydryl compounds including the thiopurine drugs ([@B94]), also displayed reduced expression in SNEB cows. Considering that in human studies, patients expressing low levels of this gene require dose adjustments when receiving thiopurine drugs to avoid severe toxicity ([@B75]), a reduction in the expression of this gene in periparturient cows might suggest suboptimal health status. The CHUK gene is responsible for activation of the transcriptional regulator NF-κB and is therefore critical to this signaling pathway ([@B64]). Also, it has been documented that NF-κB is an important transcription factor complex involved in almost every aspect of cell regulation including initiation of immune responses and cellular proliferation ([@B87]). NF-κB deregulation is associated with a deviation from normal cell growth ([@B91]). Therefore, perhaps SNEB cows are subject to impaired hepatic cell growth and repair during the early postpartum period when CHUK expression is depressed.

In the second most significant network the GK gene is upregulated by SNEB. GK converts glycerol and ATP to glycerol-3-phosphate and ADP ([@B13]). This intermediate step is more than likely directed toward glycolysis rather than gluconeogenesis in SNEB cows attempting to deal with a drastic energy deficit. The CD69 gene is usually induced on activation of T lymphocytes and functions as a signal-transmitting receptor in lymphocytes, natural killer cells, and platelets ([@B9]). Therefore, increased expression of the CD69 gene may suggest an increased immune response in SNEB cows; however, upregulation of this gene alone is not sufficient to signify alterations in the immune system particularly given that a companion study examining the influence of SNEB on splenic gene expression by Morris et al. ([@B66]) reported evidence of a depressed immune system in these cows. The cell surface receptor PLAUR, which is involved in proteolytic degradation by converting plasminogen to the active form plasmin, was also increased in the more metabolically challenged cows, and the recent studies by Morris et al. ([@B66]) and Wathes et al. ([@B93]) reported similar alterations in expression of this gene in the spleen and uterine tissues, respectively, of SNEB cows. Again, the link between increased abnormal or unexpected gene expression and SNEB is apparent, as Foca et al. ([@B20]) previously reported that PLAUR mRNA levels were positively correlated with the invasive potential of endometrial carcinomas. Similarly, the IL1RN gene that inhibits the activities of interleukin 1 alpha (IL1A) and interleukin 1 beta (IL1B) was increased. As a consequence, these cytokines are neutralized in physiological immune and inflammatory responses ([@B1], [@B10]), an event that is consistent with both the reduced expression of CHUK and NF-κB genes associated with IL regulation ([@B59]) and the findings of a depressed immune response in SNEB cows reported by Morris et al. ([@B66]). Muller et al. ([@B67]) found the CXCR4 gene to be highly expressed in cells with abnormal cell cycle but is undetectable in normal tissue. Upregulation of CXCR4, in this study, is indicative of poor animal health or reduced hepatic performance during periods of SNEB. Similarly, expression of the cell surface antigen TM4SF1 was increased in SNEB cows and is known to be highly expressed in different carcinomas ([@B82]).

The RGS16 gene, which negatively influences G protein signaling ([@B62]), was increased in SNEB cows, thus interrupting normal signal transduction in these animals. Furthermore, SNEB downregulation of ARL4D, thought to be involved in small GTPase-mediated signal transduction and protein secretion ([@B33], [@B50]), and RAB5A member, which is involved in signal transduction, endocytosis, and mitogenesis ([@B65]), is concomitant with the large-scale decrease in signaling events. Likewise SMAD proteins mediate TGF-β signaling to regulate cell growth and differentiation ([@B31]), however, SMAD2 being downregulated in the SNEB cows may not fulfill its role in the intracellular signaling cascade and positive regulation of transcription ([@B35]) to the same extent as in MNEB cows. Notably, another gene downregulated was SUGT1, which is required for the G1/S and G2/M transitions of the cell cycle ([@B43]). Hence, this expression pattern is likely to have a negative impact on tissue growth and repair mechanisms. All of these downregulated genes provide evidence that cell growth and proliferation are compromised in SNEB cows.

From analysis of IPA *network \#3*, the common theme in this study is again evident. SNEB cows appear to experience decreased cell signaling, tissue growth, and repair processes, while they contend with an apparent increase in expression of genes associated with abnormal cell cycle or cellular proliferation. The FOS gene encoding an oncoprotein that is involved in promoting the transcription of genes containing AP-1 regulatory elements ([@B2]) displayed increased expression in this network. Interestingly FOS is also associated with liver regeneration as expression is induced after partial hepatectomy in mice ([@B85]) and may be involved in the cellular response to ROS. Similarly upregulated was GSTM4, a gene important for detoxification of physiological products of oxidative stress ([@B15]), which are likely to be present in the SNEB cows ([@B66]).

The ID2 gene has proliferative effects and is increased in SNEB cows; however, the gene is also known to affect the cell cycle as it disrupts regulator proteins ([@B26], [@B46], [@B47]). The upregulation of this gene provides further evidence that any increased expression of growth-promoting genes in SNEB cows appears to be toward those with possible deleterious effects on cow health. The RNF4 gene, which was upregulated in SNEB cows, possesses both growth-inhibiting ([@B73]) and growth-promoting properties ([@B69]); therefore, it is difficult to assess what its role may be in terms of differential EB status in the cow. FARS2, involved in the processes of translation and tRNA processing ([@B8]), was downregulated in SNEB cows, as was GJA1, which is involved in cell-to-cell adhesion and direct intercellular communication and usually increased by the cell cycle ([@B49]). Likewise, NFIA, involved in DNA replication and transcriptional regulation ([@B51], [@B57]), and SELENBP1, which acts as a transporter protein, were also downregulated. In mouse models it has been reported that expression of the SELENBP1 gene is reduced in response to PPAR agonists that are known to be in circulation in SNEB cows and are therefore more than likely responsible for SELENBP1 downregulation in these cows. Such downregulation has been reported to enhance cellular proliferation, but this is again associated with some level of carcinogenicity ([@B24]). Concomitant with this we also observed reduced expression of RB1, which encodes a tumor suppressor protein ([@B95]).

In conclusion, from a global examination of hepatic gene expression in cows with differing EB status, we see that SNEB increases expression of genes associated with lipid catabolism and appears to have a negative or inhibitory impact on cell growth and repair. In addition, there is an apparent decrease in DNA replication, with a tendency toward abnormal or unregulated cell cycle progression in SNEB cows. Taken together there appears to be strong links between the increased circulation of metabolic by-products (PPAR agonists), decreased normal functional activity, and increased susceptibility to abnormal gene expression in hepatic tissue of dairy cows experiencing SNEB.
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